nodes	percent_of_prediction	percent_of_DWPC	metapath
Adapalene—Foetal disorder—Estradiol—osteoporosis	0.0524	0.105	CcSEcCtD
Adapalene—Skin discomfort—Calcitriol—osteoporosis	0.0487	0.0974	CcSEcCtD
Adapalene—Lip swelling—Calcitriol—osteoporosis	0.0323	0.0647	CcSEcCtD
Adapalene—Drug ineffective—Estradiol—osteoporosis	0.0182	0.0365	CcSEcCtD
Adapalene—Pain of skin—Estradiol—osteoporosis	0.0134	0.0268	CcSEcCtD
Adapalene—Stinging—Calcium Acetate—osteoporosis	0.013	0.026	CcSEcCtD
Adapalene—Sunburn—Estradiol—osteoporosis	0.0105	0.0209	CcSEcCtD
Adapalene—Optic neuritis—Estropipate—osteoporosis	0.00971	0.0194	CcSEcCtD
Adapalene—Redness—Ibandronate—osteoporosis	0.00849	0.017	CcSEcCtD
Adapalene—Redness—Calcitriol—osteoporosis	0.00831	0.0166	CcSEcCtD
Adapalene—Dermatitis atopic—Ibandronate—osteoporosis	0.00774	0.0155	CcSEcCtD
Adapalene—Feeling hot—Ibandronate—osteoporosis	0.0073	0.0146	CcSEcCtD
Adapalene—Redness—Pamidronate—osteoporosis	0.00665	0.0133	CcSEcCtD
Adapalene—Optic neuritis—Conjugated Estrogens—osteoporosis	0.00642	0.0129	CcSEcCtD
Adapalene—Dermatitis atopic—Risedronate—osteoporosis	0.00638	0.0128	CcSEcCtD
Adapalene—Eyelid oedema—Estradiol—osteoporosis	0.00626	0.0125	CcSEcCtD
Adapalene—Redness—Zoledronate—osteoporosis	0.00607	0.0122	CcSEcCtD
Adapalene—RXRG—Nuclear Receptors—ESR2—osteoporosis	0.00543	0.0108	CbGpPWpGaD
Adapalene—RARB—Nuclear Receptors—ESR2—osteoporosis	0.00532	0.0106	CbGpPWpGaD
Adapalene—Herpes simplex—Ethinyl Estradiol—osteoporosis	0.00526	0.0105	CcSEcCtD
Adapalene—RXRG—Retinoic acid receptors-mediated signaling—VDR—osteoporosis	0.0052	0.0104	CbGpPWpGaD
Adapalene—RARG—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—osteoporosis	0.00515	0.0103	CbGpPWpGaD
Adapalene—Optic neuritis—Estradiol—osteoporosis	0.00514	0.0103	CcSEcCtD
Adapalene—RARB—Retinoic acid receptors-mediated signaling—VDR—osteoporosis	0.0051	0.0102	CbGpPWpGaD
Adapalene—RARA—Nuclear Receptors—ESR2—osteoporosis	0.0051	0.0102	CbGpPWpGaD
Adapalene—RXRB—Nuclear Receptors—ESR2—osteoporosis	0.0051	0.0102	CbGpPWpGaD
Adapalene—Feeling hot—Conjugated Estrogens—osteoporosis	0.00503	0.0101	CcSEcCtD
Adapalene—RARA—Retinoic acid receptors-mediated signaling—VDR—osteoporosis	0.00489	0.00977	CbGpPWpGaD
Adapalene—RXRB—Retinoic acid receptors-mediated signaling—VDR—osteoporosis	0.00489	0.00977	CbGpPWpGaD
Adapalene—Herpes simplex—Pamidronate—osteoporosis	0.00487	0.00975	CcSEcCtD
Adapalene—RXRA—Bile acid and bile salt metabolism—CYP27A1—osteoporosis	0.0048	0.00959	CbGpPWpGaD
Adapalene—RARG—Nuclear Receptors—VDR—osteoporosis	0.00471	0.00941	CbGpPWpGaD
Adapalene—RARG—Nuclear Receptor transcription pathway—ESR2—osteoporosis	0.00469	0.00937	CbGpPWpGaD
Adapalene—Redness—Estradiol—osteoporosis	0.00468	0.00937	CcSEcCtD
Adapalene—RARB—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—osteoporosis	0.00462	0.00922	CbGpPWpGaD
Adapalene—Dermatitis bullous—Estropipate—osteoporosis	0.00454	0.00909	CcSEcCtD
Adapalene—RARA—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—osteoporosis	0.00443	0.00884	CbGpPWpGaD
Adapalene—RXRG—Nuclear Receptors—VDR—osteoporosis	0.00431	0.0086	CbGpPWpGaD
Adapalene—RXRG—Nuclear Receptor transcription pathway—ESR2—osteoporosis	0.00429	0.00857	CbGpPWpGaD
Adapalene—RXRA—Pyruvate metabolism and Citric Acid (TCA) cycle—IDH2—osteoporosis	0.00427	0.00853	CbGpPWpGaD
Adapalene—Dermatitis bullous—Calcitriol—osteoporosis	0.00426	0.00853	CcSEcCtD
Adapalene—RARB—Nuclear Receptors—VDR—osteoporosis	0.00422	0.00844	CbGpPWpGaD
Adapalene—RARB—Nuclear Receptor transcription pathway—ESR2—osteoporosis	0.0042	0.0084	CbGpPWpGaD
Adapalene—RARA—Nuclear Receptors—VDR—osteoporosis	0.00405	0.00809	CbGpPWpGaD
Adapalene—RXRB—Nuclear Receptors—VDR—osteoporosis	0.00405	0.00809	CbGpPWpGaD
Adapalene—RXRB—Nuclear Receptor transcription pathway—ESR2—osteoporosis	0.00403	0.00805	CbGpPWpGaD
Adapalene—RARA—Nuclear Receptor transcription pathway—ESR2—osteoporosis	0.00403	0.00805	CbGpPWpGaD
Adapalene—Face oedema—Ibandronate—osteoporosis	0.00402	0.00804	CcSEcCtD
Adapalene—Dry skin—Alendronate—osteoporosis	0.00392	0.00784	CcSEcCtD
Adapalene—Eczema—Ethinyl Estradiol—osteoporosis	0.00391	0.00783	CcSEcCtD
Adapalene—RARG—Nuclear Receptor transcription pathway—VDR—osteoporosis	0.00372	0.00743	CbGpPWpGaD
Adapalene—RXRA—Endogenous sterols—CYP19A1—osteoporosis	0.00361	0.00721	CbGpPWpGaD
Adapalene—RARG—Nuclear Receptors—ESR1—osteoporosis	0.0036	0.00719	CbGpPWpGaD
Adapalene—Skin discolouration—Estradiol—osteoporosis	0.0035	0.007	CcSEcCtD
Adapalene—Herpes simplex—Estradiol—osteoporosis	0.00343	0.00686	CcSEcCtD
Adapalene—RXRG—Nuclear Receptor transcription pathway—VDR—osteoporosis	0.0034	0.0068	CbGpPWpGaD
Adapalene—Photosensitivity reaction—Alendronate—osteoporosis	0.00337	0.00675	CcSEcCtD
Adapalene—RARB—Nuclear Receptor transcription pathway—VDR—osteoporosis	0.00334	0.00667	CbGpPWpGaD
Adapalene—Eye pain—Zoledronate—osteoporosis	0.0033	0.0066	CcSEcCtD
Adapalene—RXRG—Nuclear Receptors—ESR1—osteoporosis	0.00329	0.00657	CbGpPWpGaD
Adapalene—RARB—Nuclear Receptors—ESR1—osteoporosis	0.00323	0.00645	CbGpPWpGaD
Adapalene—Pain—Calcium Acetate—osteoporosis	0.00321	0.00643	CcSEcCtD
Adapalene—RARA—Nuclear Receptor transcription pathway—VDR—osteoporosis	0.0032	0.00639	CbGpPWpGaD
Adapalene—RXRB—Nuclear Receptor transcription pathway—VDR—osteoporosis	0.0032	0.00639	CbGpPWpGaD
Adapalene—RXRA—Cytochrome P450 - arranged by substrate type—CYP27A1—osteoporosis	0.00319	0.00637	CbGpPWpGaD
Adapalene—Conjunctivitis—Raloxifene—osteoporosis	0.00315	0.0063	CcSEcCtD
Adapalene—Dermatitis contact—Estradiol—osteoporosis	0.00312	0.00625	CcSEcCtD
Adapalene—RARA—Nuclear Receptors—ESR1—osteoporosis	0.00309	0.00618	CbGpPWpGaD
Adapalene—RXRB—Nuclear Receptors—ESR1—osteoporosis	0.00309	0.00618	CbGpPWpGaD
Adapalene—Conjunctivitis—Calcitriol—osteoporosis	0.00305	0.00611	CcSEcCtD
Adapalene—Erythema—Etidronic acid—osteoporosis	0.00302	0.00604	CcSEcCtD
Adapalene—Skin exfoliation—Estradiol—osteoporosis	0.00302	0.00604	CcSEcCtD
Adapalene—RXRA—Farnesoid X Receptor  Pathway—IRS2—osteoporosis	0.003	0.006	CbGpPWpGaD
Adapalene—Dermatitis bullous—Conjugated Estrogens—osteoporosis	0.003	0.006	CcSEcCtD
Adapalene—RXRA—RXR and RAR heterodimerization with other nuclear receptor—VDR—osteoporosis	0.00286	0.00571	CbGpPWpGaD
Adapalene—RARG—Nuclear Receptor transcription pathway—ESR1—osteoporosis	0.00284	0.00568	CbGpPWpGaD
Adapalene—Pain—Ergocalciferol—osteoporosis	0.00284	0.00568	CcSEcCtD
Adapalene—Hypersensitivity—Calcium Acetate—osteoporosis	0.00277	0.00554	CcSEcCtD
Adapalene—Angioedema—Etidronic acid—osteoporosis	0.00276	0.00552	CcSEcCtD
Adapalene—RXRA—Transcription factor regulation in adipogenesis—IRS2—osteoporosis	0.00267	0.00534	CbGpPWpGaD
Adapalene—RXRA—Nuclear Receptors—ESR2—osteoporosis	0.00266	0.00531	CbGpPWpGaD
Adapalene—RXRG—Adipogenesis—WNT1—osteoporosis	0.00266	0.00531	CbGpPWpGaD
Adapalene—Pruritus—Calcium Acetate—osteoporosis	0.00266	0.00532	CcSEcCtD
Adapalene—RXRA—Transcription factor regulation in adipogenesis—LEP—osteoporosis	0.00261	0.00522	CbGpPWpGaD
Adapalene—Erythema—Estropipate—osteoporosis	0.00261	0.00523	CcSEcCtD
Adapalene—RXRG—Nuclear Receptor transcription pathway—ESR1—osteoporosis	0.0026	0.0052	CbGpPWpGaD
Adapalene—RXRA—Phase 1 - Functionalization of compounds—CYP27A1—osteoporosis	0.00258	0.00516	CbGpPWpGaD
Adapalene—Erythema—Alendronate—osteoporosis	0.00257	0.00515	CcSEcCtD
Adapalene—Conjunctivitis—Risedronate—osteoporosis	0.00257	0.00514	CcSEcCtD
Adapalene—Eczema—Estradiol—osteoporosis	0.00255	0.00511	CcSEcCtD
Adapalene—RARB—Nuclear Receptor transcription pathway—ESR1—osteoporosis	0.00255	0.0051	CbGpPWpGaD
Adapalene—RXRA—Retinoic acid receptors-mediated signaling—VDR—osteoporosis	0.00255	0.00509	CbGpPWpGaD
Adapalene—RARG—RXR and RAR heterodimerization with other nuclear receptor—TGFB1—osteoporosis	0.00253	0.00505	CbGpPWpGaD
Adapalene—Erythema—Ibandronate—osteoporosis	0.0025	0.00501	CcSEcCtD
Adapalene—RARA—Adipogenesis—WNT1—osteoporosis	0.0025	0.00499	CbGpPWpGaD
Adapalene—Erythema—Calcitriol—osteoporosis	0.00245	0.00491	CcSEcCtD
Adapalene—RXRB—Nuclear Receptor transcription pathway—ESR1—osteoporosis	0.00244	0.00488	CbGpPWpGaD
Adapalene—RARA—Nuclear Receptor transcription pathway—ESR1—osteoporosis	0.00244	0.00488	CbGpPWpGaD
Adapalene—Conjunctivitis—Pamidronate—osteoporosis	0.00244	0.00489	CcSEcCtD
Adapalene—RXRG—Adipogenesis—BMP2—osteoporosis	0.0024	0.0048	CbGpPWpGaD
Adapalene—Angioedema—Estropipate—osteoporosis	0.00239	0.00478	CcSEcCtD
Adapalene—RARG—RXR and RAR heterodimerization with other nuclear receptor—TNF—osteoporosis	0.00236	0.00472	CbGpPWpGaD
Adapalene—Angioedema—Alendronate—osteoporosis	0.00235	0.00471	CcSEcCtD
Adapalene—RXRA—Orphan transporters—ANXA2—osteoporosis	0.00235	0.00469	CbGpPWpGaD
Adapalene—RXRA—Transcription factor regulation in adipogenesis—IRS1—osteoporosis	0.00233	0.00466	CbGpPWpGaD
Adapalene—RXRG—RXR and RAR heterodimerization with other nuclear receptor—TGFB1—osteoporosis	0.00231	0.00462	CbGpPWpGaD
Adapalene—Angioedema—Ibandronate—osteoporosis	0.00229	0.00458	CcSEcCtD
Adapalene—RARB—RXR and RAR heterodimerization with other nuclear receptor—TGFB1—osteoporosis	0.00227	0.00453	CbGpPWpGaD
Adapalene—RARA—Adipogenesis—BMP2—osteoporosis	0.00226	0.00451	CbGpPWpGaD
Adapalene—Conjunctivitis—Zoledronate—osteoporosis	0.00223	0.00446	CcSEcCtD
Adapalene—Face oedema—Estradiol—osteoporosis	0.00221	0.00443	CcSEcCtD
Adapalene—RXRA—Fatty acid, triacylglycerol, and ketone body metabolism—GPD2—osteoporosis	0.00219	0.00437	CbGpPWpGaD
Adapalene—RXRB—RXR and RAR heterodimerization with other nuclear receptor—TGFB1—osteoporosis	0.00217	0.00434	CbGpPWpGaD
Adapalene—RARA—RXR and RAR heterodimerization with other nuclear receptor—TGFB1—osteoporosis	0.00217	0.00434	CbGpPWpGaD
Adapalene—RXRA—Endogenous sterols—POMC—osteoporosis	0.00217	0.00433	CbGpPWpGaD
Adapalene—RXRG—RXR and RAR heterodimerization with other nuclear receptor—TNF—osteoporosis	0.00216	0.00432	CbGpPWpGaD
Adapalene—Convulsion—Calcitriol—osteoporosis	0.00212	0.00425	CcSEcCtD
Adapalene—RARB—RXR and RAR heterodimerization with other nuclear receptor—TNF—osteoporosis	0.00212	0.00423	CbGpPWpGaD
Adapalene—RXRA—Nuclear Receptors—VDR—osteoporosis	0.00211	0.00422	CbGpPWpGaD
Adapalene—Dry skin—Estradiol—osteoporosis	0.0021	0.00421	CcSEcCtD
Adapalene—RXRA—Nuclear Receptor transcription pathway—ESR2—osteoporosis	0.0021	0.0042	CbGpPWpGaD
Adapalene—RARB—Integrated Pancreatic Cancer Pathway—RAP1A—osteoporosis	0.00205	0.0041	CbGpPWpGaD
Adapalene—RARA—RXR and RAR heterodimerization with other nuclear receptor—TNF—osteoporosis	0.00203	0.00406	CbGpPWpGaD
Adapalene—RXRB—RXR and RAR heterodimerization with other nuclear receptor—TNF—osteoporosis	0.00203	0.00406	CbGpPWpGaD
Adapalene—RXRA—Transcriptional regulation of white adipocyte differentiation—WNT1—osteoporosis	0.00198	0.00395	CbGpPWpGaD
Adapalene—RARA—Integrated Pancreatic Cancer Pathway—RAP1A—osteoporosis	0.00197	0.00394	CbGpPWpGaD
Adapalene—Erythema—Pamidronate—osteoporosis	0.00196	0.00393	CcSEcCtD
Adapalene—Urticaria—Etidronic acid—osteoporosis	0.00196	0.00392	CcSEcCtD
Adapalene—Angioedema—Ethinyl Estradiol—osteoporosis	0.00193	0.00387	CcSEcCtD
Adapalene—Angioedema—Risedronate—osteoporosis	0.00189	0.00378	CcSEcCtD
Adapalene—Pain—Estropipate—osteoporosis	0.00182	0.00365	CcSEcCtD
Adapalene—Hypersensitivity—Etidronic acid—osteoporosis	0.00182	0.00363	CcSEcCtD
Adapalene—Photosensitivity reaction—Estradiol—osteoporosis	0.00181	0.00362	CcSEcCtD
Adapalene—Pain—Alendronate—osteoporosis	0.0018	0.00359	CcSEcCtD
Adapalene—Angioedema—Pamidronate—osteoporosis	0.00179	0.00359	CcSEcCtD
Adapalene—Erythema—Zoledronate—osteoporosis	0.00179	0.00359	CcSEcCtD
Adapalene—Pain—Raloxifene—osteoporosis	0.00177	0.00354	CcSEcCtD
Adapalene—Pain—Ibandronate—osteoporosis	0.00175	0.0035	CcSEcCtD
Adapalene—Pruritus—Etidronic acid—osteoporosis	0.00174	0.00349	CcSEcCtD
Adapalene—Erythema—Conjugated Estrogens—osteoporosis	0.00173	0.00346	CcSEcCtD
Adapalene—Conjunctivitis—Estradiol—osteoporosis	0.00172	0.00344	CcSEcCtD
Adapalene—Pain—Calcitriol—osteoporosis	0.00171	0.00343	CcSEcCtD
Adapalene—Convulsion—Pamidronate—osteoporosis	0.0017	0.0034	CcSEcCtD
Adapalene—RXRA—Fatty acid, triacylglycerol, and ketone body metabolism—OXCT1—osteoporosis	0.0017	0.0034	CbGpPWpGaD
Adapalene—Urticaria—Estropipate—osteoporosis	0.00169	0.00339	CcSEcCtD
Adapalene—RXRA—Cytochrome P450 - arranged by substrate type—CYP19A1—osteoporosis	0.00168	0.00335	CbGpPWpGaD
Adapalene—Urticaria—Alendronate—osteoporosis	0.00167	0.00334	CcSEcCtD
Adapalene—RXRA—Nuclear Receptor transcription pathway—VDR—osteoporosis	0.00167	0.00333	CbGpPWpGaD
Adapalene—RXRA—The citric acid (TCA) cycle and respiratory electron transport—IDH2—osteoporosis	0.00166	0.00331	CbGpPWpGaD
Adapalene—Angioedema—Zoledronate—osteoporosis	0.00164	0.00328	CcSEcCtD
Adapalene—Urticaria—Ibandronate—osteoporosis	0.00162	0.00325	CcSEcCtD
Adapalene—RXRA—Nuclear Receptors—ESR1—osteoporosis	0.00161	0.00322	CbGpPWpGaD
Adapalene—Urticaria—Calcitriol—osteoporosis	0.00159	0.00318	CcSEcCtD
Adapalene—Hepatitis—Estradiol—osteoporosis	0.00159	0.00318	CcSEcCtD
Adapalene—Angioedema—Conjugated Estrogens—osteoporosis	0.00158	0.00316	CcSEcCtD
Adapalene—Hypersensitivity—Estropipate—osteoporosis	0.00157	0.00314	CcSEcCtD
Adapalene—Rash—Etidronic acid—osteoporosis	0.00155	0.00311	CcSEcCtD
Adapalene—Convulsion—Zoledronate—osteoporosis	0.00155	0.00311	CcSEcCtD
Adapalene—Dermatitis—Etidronic acid—osteoporosis	0.00155	0.00311	CcSEcCtD
Adapalene—Hypersensitivity—Alendronate—osteoporosis	0.00155	0.0031	CcSEcCtD
Adapalene—Pruritus—Estropipate—osteoporosis	0.00151	0.00302	CcSEcCtD
Adapalene—Hypersensitivity—Ibandronate—osteoporosis	0.00151	0.00302	CcSEcCtD
Adapalene—Convulsion—Conjugated Estrogens—osteoporosis	0.0015	0.00299	CcSEcCtD
Adapalene—Pruritus—Alendronate—osteoporosis	0.00149	0.00297	CcSEcCtD
Adapalene—Hypersensitivity—Calcitriol—osteoporosis	0.00147	0.00295	CcSEcCtD
Adapalene—RARB—Integrated Pancreatic Cancer Pathway—ESR2—osteoporosis	0.00146	0.00292	CbGpPWpGaD
Adapalene—Pruritus—Ibandronate—osteoporosis	0.00145	0.0029	CcSEcCtD
Adapalene—Pain—Risedronate—osteoporosis	0.00144	0.00288	CcSEcCtD
Adapalene—Pruritus—Calcitriol—osteoporosis	0.00142	0.00283	CcSEcCtD
Adapalene—RARA—Integrated Pancreatic Cancer Pathway—ESR2—osteoporosis	0.0014	0.0028	CbGpPWpGaD
Adapalene—Erythema—Estradiol—osteoporosis	0.00138	0.00277	CcSEcCtD
Adapalene—RXRA—Biological oxidations—CYP27A1—osteoporosis	0.00137	0.00274	CbGpPWpGaD
Adapalene—Urticaria—Ethinyl Estradiol—osteoporosis	0.00137	0.00275	CcSEcCtD
Adapalene—Pain—Pamidronate—osteoporosis	0.00137	0.00274	CcSEcCtD
Adapalene—RXRA—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	0.00136	0.00271	CbGpPWpGaD
Adapalene—Rash—Estropipate—osteoporosis	0.00134	0.00269	CcSEcCtD
Adapalene—Dermatitis—Estropipate—osteoporosis	0.00134	0.00269	CcSEcCtD
Adapalene—Urticaria—Risedronate—osteoporosis	0.00134	0.00268	CcSEcCtD
Adapalene—Rash—Alendronate—osteoporosis	0.00132	0.00265	CcSEcCtD
Adapalene—Dermatitis—Alendronate—osteoporosis	0.00132	0.00265	CcSEcCtD
Adapalene—RXRG—Adipogenesis—IRS2—osteoporosis	0.00132	0.00263	CbGpPWpGaD
Adapalene—Rash—Raloxifene—osteoporosis	0.0013	0.00261	CcSEcCtD
Adapalene—RXRA—Adipogenesis—WNT1—osteoporosis	0.0013	0.0026	CbGpPWpGaD
Adapalene—Dermatitis—Raloxifene—osteoporosis	0.0013	0.0026	CcSEcCtD
Adapalene—Rash—Ibandronate—osteoporosis	0.00129	0.00258	CcSEcCtD
Adapalene—RXRG—Adipogenesis—LEP—osteoporosis	0.00129	0.00257	CbGpPWpGaD
Adapalene—Dermatitis—Ibandronate—osteoporosis	0.00129	0.00258	CcSEcCtD
Adapalene—RXRA—Nuclear Receptor transcription pathway—ESR1—osteoporosis	0.00127	0.00255	CbGpPWpGaD
Adapalene—Hypersensitivity—Ethinyl Estradiol—osteoporosis	0.00127	0.00255	CcSEcCtD
Adapalene—Angioedema—Estradiol—osteoporosis	0.00126	0.00253	CcSEcCtD
Adapalene—Rash—Calcitriol—osteoporosis	0.00126	0.00253	CcSEcCtD
Adapalene—Dermatitis—Calcitriol—osteoporosis	0.00126	0.00252	CcSEcCtD
Adapalene—Pain—Zoledronate—osteoporosis	0.00125	0.0025	CcSEcCtD
Adapalene—Hypersensitivity—Risedronate—osteoporosis	0.00124	0.00249	CcSEcCtD
Adapalene—RARA—Adipogenesis—IRS2—osteoporosis	0.00124	0.00247	CbGpPWpGaD
Adapalene—Pruritus—Ethinyl Estradiol—osteoporosis	0.00122	0.00245	CcSEcCtD
Adapalene—RARA—Adipogenesis—LEP—osteoporosis	0.00121	0.00242	CbGpPWpGaD
Adapalene—RXRA—Transcription factor regulation in adipogenesis—TNF—osteoporosis	0.00121	0.00242	CbGpPWpGaD
Adapalene—Pain—Conjugated Estrogens—osteoporosis	0.0012	0.00241	CcSEcCtD
Adapalene—Pruritus—Risedronate—osteoporosis	0.00119	0.00239	CcSEcCtD
Adapalene—Hypersensitivity—Pamidronate—osteoporosis	0.00118	0.00236	CcSEcCtD
Adapalene—RXRA—Adipogenesis—BMP2—osteoporosis	0.00118	0.00235	CbGpPWpGaD
Adapalene—Urticaria—Zoledronate—osteoporosis	0.00116	0.00233	CcSEcCtD
Adapalene—RXRG—Adipogenesis—IRS1—osteoporosis	0.00115	0.0023	CbGpPWpGaD
Adapalene—RXRA—PPAR Alpha Pathway—MYC—osteoporosis	0.00114	0.00227	CbGpPWpGaD
Adapalene—RXRA—RXR and RAR heterodimerization with other nuclear receptor—TGFB1—osteoporosis	0.00113	0.00226	CbGpPWpGaD
Adapalene—Pruritus—Pamidronate—osteoporosis	0.00113	0.00227	CcSEcCtD
Adapalene—Urticaria—Conjugated Estrogens—osteoporosis	0.00112	0.00224	CcSEcCtD
Adapalene—Rash—Ethinyl Estradiol—osteoporosis	0.00109	0.00218	CcSEcCtD
Adapalene—Dermatitis—Ethinyl Estradiol—osteoporosis	0.00109	0.00218	CcSEcCtD
Adapalene—RARA—Adipogenesis—IRS1—osteoporosis	0.00108	0.00216	CbGpPWpGaD
Adapalene—Hypersensitivity—Zoledronate—osteoporosis	0.00108	0.00216	CcSEcCtD
Adapalene—RXRG—Adipogenesis—IGF1—osteoporosis	0.00106	0.00213	CbGpPWpGaD
Adapalene—Rash—Risedronate—osteoporosis	0.00106	0.00213	CcSEcCtD
Adapalene—Dermatitis—Risedronate—osteoporosis	0.00106	0.00212	CcSEcCtD
Adapalene—RXRA—RXR and RAR heterodimerization with other nuclear receptor—TNF—osteoporosis	0.00106	0.00211	CbGpPWpGaD
Adapalene—Hypersensitivity—Conjugated Estrogens—osteoporosis	0.00104	0.00208	CcSEcCtD
Adapalene—Pruritus—Zoledronate—osteoporosis	0.00104	0.00207	CcSEcCtD
Adapalene—RXRA—Integrated Pancreatic Cancer Pathway—RAP1A—osteoporosis	0.00103	0.00205	CbGpPWpGaD
Adapalene—RARG—Gene Expression—U2AF1—osteoporosis	0.00102	0.00203	CbGpPWpGaD
Adapalene—Rash—Pamidronate—osteoporosis	0.00101	0.00202	CcSEcCtD
Adapalene—Dermatitis—Pamidronate—osteoporosis	0.00101	0.00202	CcSEcCtD
Adapalene—RXRA—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	0.00101	0.00201	CbGpPWpGaD
Adapalene—RARA—Adipogenesis—IGF1—osteoporosis	0.001	0.002	CbGpPWpGaD
Adapalene—Pruritus—Conjugated Estrogens—osteoporosis	0.000997	0.002	CcSEcCtD
Adapalene—RXRA—Transcription factor regulation in adipogenesis—IL6—osteoporosis	0.000976	0.00195	CbGpPWpGaD
Adapalene—Pain—Estradiol—osteoporosis	0.000964	0.00193	CcSEcCtD
Adapalene—RXRA—Transcriptional regulation of white adipocyte differentiation—LEP—osteoporosis	0.00096	0.00192	CbGpPWpGaD
Adapalene—RXRG—Gene Expression—U2AF1—osteoporosis	0.00093	0.00186	CbGpPWpGaD
Adapalene—RXRA—Developmental Biology—CAP1—osteoporosis	0.00093	0.00186	CbGpPWpGaD
Adapalene—Rash—Zoledronate—osteoporosis	0.000922	0.00185	CcSEcCtD
Adapalene—Dermatitis—Zoledronate—osteoporosis	0.000922	0.00184	CcSEcCtD
Adapalene—RXRA—Metabolism of lipids and lipoproteins—FDPS—osteoporosis	0.000918	0.00183	CbGpPWpGaD
Adapalene—RARB—Gene Expression—U2AF1—osteoporosis	0.000912	0.00182	CbGpPWpGaD
Adapalene—Urticaria—Estradiol—osteoporosis	0.000896	0.00179	CcSEcCtD
Adapalene—Rash—Conjugated Estrogens—osteoporosis	0.000888	0.00178	CcSEcCtD
Adapalene—Dermatitis—Conjugated Estrogens—osteoporosis	0.000887	0.00178	CcSEcCtD
Adapalene—RARB—Integrated Pancreatic Cancer Pathway—ESR1—osteoporosis	0.000887	0.00177	CbGpPWpGaD
Adapalene—RXRB—Gene Expression—U2AF1—osteoporosis	0.000875	0.00175	CbGpPWpGaD
Adapalene—RARA—Gene Expression—U2AF1—osteoporosis	0.000875	0.00175	CbGpPWpGaD
Adapalene—RXRA—Metabolism of lipids and lipoproteins—GPD2—osteoporosis	0.00087	0.00174	CbGpPWpGaD
Adapalene—RARA—Integrated Pancreatic Cancer Pathway—ESR1—osteoporosis	0.00085	0.0017	CbGpPWpGaD
Adapalene—Hypersensitivity—Estradiol—osteoporosis	0.000831	0.00166	CcSEcCtD
Adapalene—RXRA—Phase 1 - Functionalization of compounds—POMC—osteoporosis	0.000816	0.00163	CbGpPWpGaD
Adapalene—RARG—Generic Transcription Pathway—ESR2—osteoporosis	0.00081	0.00162	CbGpPWpGaD
Adapalene—Pruritus—Estradiol—osteoporosis	0.000798	0.0016	CcSEcCtD
Adapalene—RARB—Integrated Pancreatic Cancer Pathway—IGF1—osteoporosis	0.000767	0.00153	CbGpPWpGaD
Adapalene—RARG—Gene Expression—RPL24—osteoporosis	0.000756	0.00151	CbGpPWpGaD
Adapalene—RXRG—Generic Transcription Pathway—ESR2—osteoporosis	0.000741	0.00148	CbGpPWpGaD
Adapalene—RARA—Integrated Pancreatic Cancer Pathway—IGF1—osteoporosis	0.000736	0.00147	CbGpPWpGaD
Adapalene—RXRA—Integrated Pancreatic Cancer Pathway—ESR2—osteoporosis	0.00073	0.00146	CbGpPWpGaD
Adapalene—RARB—Generic Transcription Pathway—ESR2—osteoporosis	0.000726	0.00145	CbGpPWpGaD
Adapalene—RXRA—Biological oxidations—CYP19A1—osteoporosis	0.000721	0.00144	CbGpPWpGaD
Adapalene—Rash—Estradiol—osteoporosis	0.000711	0.00142	CcSEcCtD
Adapalene—Dermatitis—Estradiol—osteoporosis	0.00071	0.00142	CcSEcCtD
Adapalene—RARA—Generic Transcription Pathway—ESR2—osteoporosis	0.000696	0.00139	CbGpPWpGaD
Adapalene—RXRB—Generic Transcription Pathway—ESR2—osteoporosis	0.000696	0.00139	CbGpPWpGaD
Adapalene—RXRG—Gene Expression—RPL24—osteoporosis	0.000691	0.00138	CbGpPWpGaD
Adapalene—RARB—Gene Expression—RPL24—osteoporosis	0.000678	0.00135	CbGpPWpGaD
Adapalene—RXRA—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	0.000677	0.00135	CbGpPWpGaD
Adapalene—RXRA—NRF2 pathway—AGER—osteoporosis	0.000674	0.00135	CbGpPWpGaD
Adapalene—RXRA—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	0.00066	0.00132	CbGpPWpGaD
Adapalene—RXRB—Gene Expression—RPL24—osteoporosis	0.00065	0.0013	CbGpPWpGaD
Adapalene—RARA—Gene Expression—RPL24—osteoporosis	0.00065	0.0013	CbGpPWpGaD
Adapalene—RXRA—Adipogenesis—IRS2—osteoporosis	0.000645	0.00129	CbGpPWpGaD
Adapalene—RARG—Generic Transcription Pathway—VDR—osteoporosis	0.000643	0.00128	CbGpPWpGaD
Adapalene—RXRG—Adipogenesis—TGFB1—osteoporosis	0.000638	0.00128	CbGpPWpGaD
Adapalene—RXRA—Adipogenesis—LEP—osteoporosis	0.000631	0.00126	CbGpPWpGaD
Adapalene—RARA—Adipogenesis—TGFB1—osteoporosis	0.0006	0.0012	CbGpPWpGaD
Adapalene—RXRG—Adipogenesis—TNF—osteoporosis	0.000596	0.00119	CbGpPWpGaD
Adapalene—RXRG—Generic Transcription Pathway—VDR—osteoporosis	0.000588	0.00117	CbGpPWpGaD
Adapalene—RXRA—Developmental Biology—TLN1—osteoporosis	0.000582	0.00116	CbGpPWpGaD
Adapalene—RARB—Generic Transcription Pathway—VDR—osteoporosis	0.000576	0.00115	CbGpPWpGaD
Adapalene—RXRA—Developmental Biology—ACTG1—osteoporosis	0.000574	0.00115	CbGpPWpGaD
Adapalene—RXRA—Transmembrane transport of small molecules—ANXA2—osteoporosis	0.000574	0.00115	CbGpPWpGaD
Adapalene—RXRA—Adipogenesis—IRS1—osteoporosis	0.000563	0.00113	CbGpPWpGaD
Adapalene—RARA—Adipogenesis—TNF—osteoporosis	0.00056	0.00112	CbGpPWpGaD
Adapalene—RXRB—Generic Transcription Pathway—VDR—osteoporosis	0.000553	0.0011	CbGpPWpGaD
Adapalene—RARA—Generic Transcription Pathway—VDR—osteoporosis	0.000553	0.0011	CbGpPWpGaD
Adapalene—RXRA—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	0.000527	0.00105	CbGpPWpGaD
Adapalene—RXRA—Adipogenesis—IGF1—osteoporosis	0.000522	0.00104	CbGpPWpGaD
Adapalene—RARG—Generic Transcription Pathway—ESR1—osteoporosis	0.000491	0.000981	CbGpPWpGaD
Adapalene—RXRG—Adipogenesis—IL6—osteoporosis	0.000481	0.000961	CbGpPWpGaD
Adapalene—RXRA—Transcriptional regulation of white adipocyte differentiation—TGFB1—osteoporosis	0.000475	0.00095	CbGpPWpGaD
Adapalene—RARB—Integrated Pancreatic Cancer Pathway—MYC—osteoporosis	0.000461	0.000922	CbGpPWpGaD
Adapalene—RARB—Integrated Pancreatic Cancer Pathway—TGFB1—osteoporosis	0.00046	0.000919	CbGpPWpGaD
Adapalene—RXRA—Gene Expression—U2AF1—osteoporosis	0.000456	0.000911	CbGpPWpGaD
Adapalene—RARA—Adipogenesis—IL6—osteoporosis	0.000452	0.000903	CbGpPWpGaD
Adapalene—RXRG—Generic Transcription Pathway—ESR1—osteoporosis	0.000449	0.000897	CbGpPWpGaD
Adapalene—RXRA—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	0.000448	0.000896	CbGpPWpGaD
Adapalene—RXRA—Developmental Biology—WNT1—osteoporosis	0.000447	0.000894	CbGpPWpGaD
Adapalene—RXRA—Transcriptional regulation of white adipocyte differentiation—TNF—osteoporosis	0.000444	0.000887	CbGpPWpGaD
Adapalene—RXRA—Integrated Pancreatic Cancer Pathway—ESR1—osteoporosis	0.000443	0.000885	CbGpPWpGaD
Adapalene—RARA—Integrated Pancreatic Cancer Pathway—MYC—osteoporosis	0.000442	0.000883	CbGpPWpGaD
Adapalene—RARA—Integrated Pancreatic Cancer Pathway—TGFB1—osteoporosis	0.000441	0.000881	CbGpPWpGaD
Adapalene—RARB—Generic Transcription Pathway—ESR1—osteoporosis	0.00044	0.00088	CbGpPWpGaD
Adapalene—RARG—Gene Expression—PSMA2—osteoporosis	0.000436	0.000872	CbGpPWpGaD
Adapalene—RARG—Gene Expression—PSMA5—osteoporosis	0.000436	0.000872	CbGpPWpGaD
Adapalene—RXRA—Biological oxidations—POMC—osteoporosis	0.000433	0.000866	CbGpPWpGaD
Adapalene—RARB—Integrated Pancreatic Cancer Pathway—TNF—osteoporosis	0.00043	0.000858	CbGpPWpGaD
Adapalene—RARA—Generic Transcription Pathway—ESR1—osteoporosis	0.000422	0.000844	CbGpPWpGaD
Adapalene—RXRB—Generic Transcription Pathway—ESR1—osteoporosis	0.000422	0.000844	CbGpPWpGaD
Adapalene—RARA—Integrated Pancreatic Cancer Pathway—TNF—osteoporosis	0.000412	0.000823	CbGpPWpGaD
Adapalene—RXRA—Metabolism—PKM—osteoporosis	0.000409	0.000817	CbGpPWpGaD
Adapalene—RXRA—Metabolism—FDPS—osteoporosis	0.000409	0.000817	CbGpPWpGaD
Adapalene—RXRG—Gene Expression—PSMA5—osteoporosis	0.000399	0.000797	CbGpPWpGaD
Adapalene—RXRG—Gene Expression—PSMA2—osteoporosis	0.000399	0.000797	CbGpPWpGaD
Adapalene—RARB—Gene Expression—PSMA2—osteoporosis	0.000391	0.000782	CbGpPWpGaD
Adapalene—RARB—Gene Expression—PSMA5—osteoporosis	0.000391	0.000782	CbGpPWpGaD
Adapalene—RARG—Gene Expression—ESR2—osteoporosis	0.00039	0.000779	CbGpPWpGaD
Adapalene—RXRA—Metabolism—GPD2—osteoporosis	0.000388	0.000774	CbGpPWpGaD
Adapalene—RXRA—Metabolism—PGLS—osteoporosis	0.000388	0.000774	CbGpPWpGaD
Adapalene—RXRA—Integrated Pancreatic Cancer Pathway—IGF1—osteoporosis	0.000383	0.000766	CbGpPWpGaD
Adapalene—RXRB—Gene Expression—PSMA2—osteoporosis	0.000375	0.00075	CbGpPWpGaD
Adapalene—RXRB—Gene Expression—PSMA5—osteoporosis	0.000375	0.00075	CbGpPWpGaD
Adapalene—RARA—Gene Expression—PSMA5—osteoporosis	0.000375	0.00075	CbGpPWpGaD
Adapalene—RARA—Gene Expression—PSMA2—osteoporosis	0.000375	0.00075	CbGpPWpGaD
Adapalene—RXRA—Generic Transcription Pathway—ESR2—osteoporosis	0.000363	0.000725	CbGpPWpGaD
Adapalene—RXRG—Gene Expression—ESR2—osteoporosis	0.000357	0.000712	CbGpPWpGaD
Adapalene—RXRA—Metabolism—ATIC—osteoporosis	0.000354	0.000708	CbGpPWpGaD
Adapalene—RXRA—Metabolism—PNP—osteoporosis	0.000354	0.000708	CbGpPWpGaD
Adapalene—RARB—Gene Expression—ESR2—osteoporosis	0.00035	0.000699	CbGpPWpGaD
Adapalene—RXRA—Gene Expression—RPL24—osteoporosis	0.000339	0.000677	CbGpPWpGaD
Adapalene—RARA—Gene Expression—ESR2—osteoporosis	0.000335	0.00067	CbGpPWpGaD
Adapalene—RXRB—Gene Expression—ESR2—osteoporosis	0.000335	0.00067	CbGpPWpGaD
Adapalene—RXRA—Adipogenesis—TGFB1—osteoporosis	0.000313	0.000625	CbGpPWpGaD
Adapalene—RARG—Gene Expression—VDR—osteoporosis	0.000309	0.000618	CbGpPWpGaD
Adapalene—RXRA—Metabolism—CA2—osteoporosis	0.000301	0.000602	CbGpPWpGaD
Adapalene—RXRA—Metabolism—OXCT1—osteoporosis	0.000301	0.000602	CbGpPWpGaD
Adapalene—RXRA—Metabolism—MGLL—osteoporosis	0.000294	0.000587	CbGpPWpGaD
Adapalene—RXRA—Adipogenesis—TNF—osteoporosis	0.000292	0.000583	CbGpPWpGaD
Adapalene—RXRA—Generic Transcription Pathway—VDR—osteoporosis	0.000288	0.000575	CbGpPWpGaD
Adapalene—RXRA—NRF2 pathway—TGFB1—osteoporosis	0.000285	0.000569	CbGpPWpGaD
Adapalene—RXRG—Gene Expression—VDR—osteoporosis	0.000283	0.000565	CbGpPWpGaD
Adapalene—RARB—Gene Expression—VDR—osteoporosis	0.000278	0.000554	CbGpPWpGaD
Adapalene—RXRA—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	0.000277	0.000553	CbGpPWpGaD
Adapalene—RARA—Gene Expression—VDR—osteoporosis	0.000266	0.000532	CbGpPWpGaD
Adapalene—RXRB—Gene Expression—VDR—osteoporosis	0.000266	0.000532	CbGpPWpGaD
Adapalene—RARG—Generic Transcription Pathway—MYC—osteoporosis	0.000255	0.00051	CbGpPWpGaD
Adapalene—RXRA—Metabolism—IDH2—osteoporosis	0.00025	0.000499	CbGpPWpGaD
Adapalene—RARG—Gene Expression—ESR1—osteoporosis	0.000236	0.000472	CbGpPWpGaD
Adapalene—RXRA—Adipogenesis—IL6—osteoporosis	0.000236	0.000471	CbGpPWpGaD
Adapalene—RXRA—Metabolism—CYP27A1—osteoporosis	0.000235	0.000469	CbGpPWpGaD
Adapalene—RXRG—Generic Transcription Pathway—MYC—osteoporosis	0.000234	0.000467	CbGpPWpGaD
Adapalene—RXRA—Integrated Pancreatic Cancer Pathway—MYC—osteoporosis	0.00023	0.00046	CbGpPWpGaD
Adapalene—RXRA—Integrated Pancreatic Cancer Pathway—TGFB1—osteoporosis	0.00023	0.000459	CbGpPWpGaD
Adapalene—RARB—Generic Transcription Pathway—MYC—osteoporosis	0.000229	0.000458	CbGpPWpGaD
Adapalene—RXRA—Metabolism—ACP5—osteoporosis	0.000228	0.000456	CbGpPWpGaD
Adapalene—RXRA—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	0.000226	0.000451	CbGpPWpGaD
Adapalene—RXRA—Generic Transcription Pathway—ESR1—osteoporosis	0.00022	0.00044	CbGpPWpGaD
Adapalene—RARA—Generic Transcription Pathway—MYC—osteoporosis	0.00022	0.000439	CbGpPWpGaD
Adapalene—RXRB—Generic Transcription Pathway—MYC—osteoporosis	0.00022	0.000439	CbGpPWpGaD
Adapalene—RXRA—Developmental Biology—LEP—osteoporosis	0.000217	0.000434	CbGpPWpGaD
Adapalene—RXRG—Gene Expression—ESR1—osteoporosis	0.000216	0.000432	CbGpPWpGaD
Adapalene—RXRA—Transmembrane transport of small molecules—ADCY5—osteoporosis	0.000215	0.00043	CbGpPWpGaD
Adapalene—RXRA—Integrated Pancreatic Cancer Pathway—TNF—osteoporosis	0.000215	0.000429	CbGpPWpGaD
Adapalene—RXRA—Metabolism—TPI1—osteoporosis	0.000212	0.000424	CbGpPWpGaD
Adapalene—RARB—Gene Expression—ESR1—osteoporosis	0.000212	0.000424	CbGpPWpGaD
Adapalene—RARA—Gene Expression—ESR1—osteoporosis	0.000203	0.000406	CbGpPWpGaD
Adapalene—RXRB—Gene Expression—ESR1—osteoporosis	0.000203	0.000406	CbGpPWpGaD
Adapalene—RXRA—Metabolism—P4HB—osteoporosis	0.0002	0.000399	CbGpPWpGaD
Adapalene—RXRA—Metabolism—GAPDH—osteoporosis	0.000196	0.000392	CbGpPWpGaD
Adapalene—RXRA—Gene Expression—PSMA2—osteoporosis	0.000196	0.000391	CbGpPWpGaD
Adapalene—RXRA—Gene Expression—PSMA5—osteoporosis	0.000196	0.000391	CbGpPWpGaD
Adapalene—RXRA—Metabolism—RAP1A—osteoporosis	0.000191	0.000381	CbGpPWpGaD
Adapalene—RXRA—Developmental Biology—IL6R—osteoporosis	0.000182	0.000363	CbGpPWpGaD
Adapalene—RXRA—Gene Expression—ESR2—osteoporosis	0.000175	0.000349	CbGpPWpGaD
Adapalene—RXRA—Metabolism of lipids and lipoproteins—POMC—osteoporosis	0.000166	0.000333	CbGpPWpGaD
Adapalene—RXRA—Metabolism—ENO1—osteoporosis	0.000154	0.000308	CbGpPWpGaD
Adapalene—RXRA—Metabolism—PSMA2—osteoporosis	0.000152	0.000304	CbGpPWpGaD
Adapalene—RXRA—Metabolism—PSMA5—osteoporosis	0.000152	0.000304	CbGpPWpGaD
Adapalene—RXRA—Gene Expression—VDR—osteoporosis	0.000139	0.000277	CbGpPWpGaD
Adapalene—RXRA—Metabolism—CYP19A1—osteoporosis	0.000123	0.000246	CbGpPWpGaD
Adapalene—RARG—Gene Expression—MYC—osteoporosis	0.000123	0.000246	CbGpPWpGaD
Adapalene—RXRA—Generic Transcription Pathway—MYC—osteoporosis	0.000114	0.000229	CbGpPWpGaD
Adapalene—RXRG—Gene Expression—MYC—osteoporosis	0.000112	0.000225	CbGpPWpGaD
Adapalene—RARB—Gene Expression—MYC—osteoporosis	0.00011	0.00022	CbGpPWpGaD
Adapalene—RXRA—Developmental Biology—TGFB1—osteoporosis	0.000107	0.000215	CbGpPWpGaD
Adapalene—RXRA—Gene Expression—ESR1—osteoporosis	0.000106	0.000212	CbGpPWpGaD
Adapalene—RXRB—Gene Expression—MYC—osteoporosis	0.000106	0.000211	CbGpPWpGaD
Adapalene—RARA—Gene Expression—MYC—osteoporosis	0.000106	0.000211	CbGpPWpGaD
Adapalene—RXRA—Metabolism—ADCY5—osteoporosis	0.000101	0.000201	CbGpPWpGaD
Adapalene—RXRA—Metabolism—GPX1—osteoporosis	0.0001	0.000201	CbGpPWpGaD
Adapalene—RXRA—Developmental Biology—TNF—osteoporosis	0.0001	0.000201	CbGpPWpGaD
Adapalene—RXRA—Metabolism—MTHFR—osteoporosis	9.27e-05	0.000185	CbGpPWpGaD
Adapalene—RXRA—Developmental Biology—IL6—osteoporosis	8.1e-05	0.000162	CbGpPWpGaD
Adapalene—RXRA—Metabolism—POMC—osteoporosis	7.41e-05	0.000148	CbGpPWpGaD
Adapalene—RXRA—Gene Expression—MYC—osteoporosis	5.51e-05	0.00011	CbGpPWpGaD
